EDGAR Filing Documents for 0001209191-17-064325

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-17-064325

Filing Date

2017-12-07

Accepted

2017-12-07 09:57:51

Documents

Period of Report

2017-11-03

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	41594
	Complete submission text file	0001209191-17-064325.txt		43156

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901

Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000

CELGENE CORP /DE/ (Reporting) CIK: 0000816284 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 171243775
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300

Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600

CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)